295 related articles for article (PubMed ID: 34422975)
1. Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.
Zhao XJ; Liu LC; Guo C; Shen WW; Cao J; Du F; Wu DF; Yu H
Ann Transl Med; 2021 Jul; 9(13):1063. PubMed ID: 34422975
[TBL] [Abstract][Full Text] [Related]
2. Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice.
Xu Y; Li F; Zhao X; Tan C; Wang B; Chen Y; Cao J; Wu D; Yu H
FASEB J; 2020 Mar; 34(3):3805-3819. PubMed ID: 31975555
[TBL] [Abstract][Full Text] [Related]
3. Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice.
Cao J; Xu Y; Li F; Shang L; Fan D; Yu H
J Transl Med; 2018 Jun; 16(1):155. PubMed ID: 29879989
[TBL] [Abstract][Full Text] [Related]
4. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
5. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
Peng Y; Xu J; Zeng Y; Chen L; Xu XL
Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
Maïga SF; Kalopissis AD; Chabert M
Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.
Takiguchi S; Ayaori M; Yakushiji E; Nishida T; Nakaya K; Sasaki M; Iizuka M; Uto-Kondo H; Terao Y; Yogo M; Komatsu T; Ogura M; Ikewaki K
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1454-1467. PubMed ID: 29748333
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet.
Song G; Liu J; Zhao Z; Yu Y; Tian H; Yao S; Li G; Qin S
Lipids Health Dis; 2011 Jan; 10():8. PubMed ID: 21241519
[TBL] [Abstract][Full Text] [Related]
10. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
12. Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice.
Xu YY; Du F; Meng B; Xie GH; Cao J; Fan D; Yu H
J Lipid Res; 2015 Oct; 56(10):1891-900. PubMed ID: 26318157
[TBL] [Abstract][Full Text] [Related]
13. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet.
Krishna SM; Moxon JV; Jose RJ; Li J; Sahebkar A; Jaafari MR; Hatamipour M; Liu D; Golledge J
J Cell Physiol; 2018 Oct; 233(10):6951-6964. PubMed ID: 29741759
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
15. Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.
Gillard BK; Rosales C; Xu B; Gotto AM; Pownall HJ
J Clin Lipidol; 2018; 12(4):849-856. PubMed ID: 29731282
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice.
Srivastava R; Yu S; Parks BW; Black LL; Kabarowski JH
Arthritis Rheum; 2011 Jan; 63(1):201-11. PubMed ID: 20882670
[TBL] [Abstract][Full Text] [Related]
17. Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.
Berrougui H; Khalil A
Rejuvenation Res; 2009 Apr; 12(2):117-26. PubMed ID: 19405812
[TBL] [Abstract][Full Text] [Related]
18. Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice.
Farrell N; Norris G; Lee SG; Chun OK; Blesso CN
Food Funct; 2015 Apr; 6(4):1278-87. PubMed ID: 25758596
[TBL] [Abstract][Full Text] [Related]
19. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
Rosenblat M; Volkova N; Aviram M
Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
